6 employees
Teitur Trophics is a biotech company developing novel treatments for neurodegenerative diseases.
2020
$30M
from 4 investors over 4 rounds
Teitur Trophics raised $30M on March 14, 2023
Investors: Sunstone Life Science Ventures, Sound Bioventures, Industrifonden and p53